151252-19-6

Basic information

• Product Name: 1,3-Dioxolo4,5-cpyridine-4-methanol, hexahydro-7-hydroxy-2,2-dimethyl-, 3aS-(3a.alpha.,4.beta.,7.alpha.,7a.alpha.)-
• Synonyms: 1,3-Dioxolo4,5-cpyridine-4-methanol, hexahydro-7-hydroxy-2,2-dimethyl-, 3aS-(3a.alpha.,4.beta.,7.alpha.,7a.alpha.)-
• CAS NO: 151252-19-6
• Molecular Formula: C9H17 N O4
• Molecular Weight: 203.24
• Mol File: 151252-19-6.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1,3-Dioxolo4,5-cpyridine-4-methanol, hexahydro-7-hydroxy-2,2-dimethyl-, 3aS-(3a.alpha.,4.beta.,7.alpha.,7a.alpha.)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3-Dioxolo4,5-cpyridine-4-methanol, hexahydro-7-hydroxy-2,2-dimethyl-, 3aS-(3a.alpha.,4.beta.,7.alpha.,7a.alpha.)-(151252-19-6)
• EPA Substance Registry System: 1,3-Dioxolo4,5-cpyridine-4-methanol, hexahydro-7-hydroxy-2,2-dimethyl-, 3aS-(3a.alpha.,4.beta.,7.alpha.,7a.alpha.)-(151252-19-6)

Safety Data

• Hazardous Substances Data: 151252-19-6(Hazardous Substances Data)

Usage

Chemical structure

The compound has a dioxolo and pyridine ring structure, which are fused together.

Functional groups

It contains a hexahydro and hydroxy functional group, which are important for its chemical properties and reactivity.

Methyl groups

The compound has two methyl groups (2,2-dimethyl) attached to the hexahydro ring.

Stereochemistry

The compound is classified as 3aS-(3a.alpha.,4.beta.,7.alpha.,7a.alpha.)-, which describes the specific arrangement of the functional groups and atoms in the molecule.

Potential applications

The compound may have various uses in pharmaceuticals, research, or other industries, depending on its properties and behavior.

Further study

The specific properties and behavior of the compound would need to be studied in order to understand its full potential and possible applications.

Upstream product

• 1246368-39-7 C₉H₁₆O₇ 

Relevant articles and documents

Synthesis of lipophilic 1-deoxygalactonojirimycin derivatives as D-galactosidase inhibitors

N-Alkylation at the ring nitrogen of the D-galactosidase inhibitor 1-deoxygalactonojirimycin with a functionalised C6 alkyl chain followed by modification with different aromatic substituents provided lipophilic 1-deoxygalactonojirimycin derivatives which exhibit inhibitory properties against β-glycosidases from E. coli and Agrobacterium sp. as well as green coffee bean α-galactosidase. In preliminary studies, these compounds also showed potential as chemical chaperones for GM1-gangliosidosis related β-galactosidase mutants.